America Great Health (AAGH) EBITDA Margin (2015 - 2026)

America Great Health has reported EBITDA Margin for 9 years, with the latest figure at 282.2% in Q1 2026.

• On a quarterly basis, EBITDA Margin fell 13024.0% year-over-year to 282.2% in Q1 2026; TTM through Mar 2026 was 105.19%, a 7669.0% increase from a year earlier, with the FY2025 full-year figure at 97.75%, up 16787.0% from the prior year.
• EBITDA Margin was 282.2% for Q1 2026 at America Great Health, up from 440.74% in the prior quarter.
• The five-year high for EBITDA Margin was 3784.84% in Q2 2022, with the low at 23588.08% in Q1 2022.
• Average EBITDA Margin over 5 years is 1367.5%, with a median of 210.99% recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: EBITDA Margin plunged 2356402 bps in 2022, then jumped 2330487 bps in 2023.
• Over 5 years, EBITDA Margin stood at 248.78% in 2022, then soared by 32 bps to 168.75% in 2023, then gained by 21 bps to 132.52% in 2024, then slumped by 233 bps to 440.74% in 2025, then soared by 36 bps to 282.2% in 2026.
• The last three EBITDA Margin figures came in at 282.2% (Q1 2026), 440.74% (Q4 2025), and 1.8% (Q3 2025), per Business Quant data.